SCHEMBL2230637

SCHEMBL2230637

CCCc1ccn(S(=O)(=O)c2ccc(C)cc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 3/20 0.49
ALDH1A1 P00352 5/20 0.46
HTT P42858 2/20 0.46
USP2 O75604 1/20 0.46
ALOX15 P16050 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
RAPGEF4 Q8WZA2 1/20 0.43
MAPT P10636 4/20 0.43
SAE1 Q9UBE0 1/20 0.43
UBA2 Q9UBT2 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
CD4 P01730 2/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7269988 0.80 KMT2A (0.47) PKMALDH1A1HTTUSP2ALOX15
SCHEMBL21724349 0.74 ALDH1A1 (0.50) PKMALDH1A1HTTUSP2ALOX15
SCHEMBL28226553 0.74 ALDH1A1 (0.50) PKMALDH1A1HTTUSP2ALOX15
SCHEMBL568507 0.74 KMT2A (0.49) PKMALDH1A1HTTUSP2ALOX15
SCHEMBL568960 0.72 PKM (0.46) PKMALDH1A1HTTUSP2ALOX15
SCHEMBL568616 0.72 PKM (0.46) PKMALDH1A1HTTUSP2ALOX15
SCHEMBL3258659 0.72 PKM (0.46) PKMALDH1A1HTTUSP2ALOX15
SCHEMBL568658 0.72 ALDH1A1 (0.51) PKMALDH1A1HTTUSP2ALOX15
SCHEMBL20945468 0.71 F2 (0.51) PKMALDH1A1HTTUSP2ALOX15
SCHEMBL5271607 0.71 KMT2A (0.49) PKMALDH1A1HTTUSP2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346868-A1 AZAINDAZOLE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-27 EP disclosed
WO-2010036632-A1 AZAINDAZOLE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 WO disclosed